Mitobridge Company

Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions. Building upon the emerging scientific findings linking mitochondrial dysfunction with disease pathologies, the Company is progressing innovative approaches to the treatment of diseases with a high unmet medical need. Their strategy is toestablish proof of concept in rare diseases and then expand into more common diseases.
Technology: Geroscience
Industry: Small&Large Molecules
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2011
Employees Number: 11-50
Funding Status: M&A

Visit Website
Register and Claim Ownership